Tuesday, April 13, 2021
More
    Tags Oxford vaccine

    Tag: oxford vaccine

    Children as young as six join Oxford vaccine trial

    The single-blind, randomised phase II trial will include 300 volunteers. 240 participants will receive the ChAdOx1 nCoV-19 vaccine, while the remaining 60 will receive a control meningitis vaccine to act as a placebo.

    WHO provides guidance on use of Oxford vaccine

    They recommend that two standard doses of the vaccine should be given at 8- to 12-week intervals, for people aged 18 and older. This is the current strategy adopted by the United Kingdom. Clinical trials have shown that this dosing regimen is safe and effective in preventing symptomatic COVID-19.

    Oxford vaccine offers “minimal protection” against South African variant but prevents...

    In a study led by researchers from the South African University of Witwatersrand and the University of Oxford, the Oxford AstraZeneca vaccine has been found to have “minimal protection” against mild to moderate cases of the South African Covid-19 variant.

    Oxford vaccine provides sustained protection during 3-month interval until second dose

    dditionally, the Oxford vaccine may be effective in reducing transmission of coronavirus. Based on swabs obtained from volunteers in the UK, there was a 67% reduction in positive tests among those who had been vaccinated.

    Oxford vaccine effective against Kent variant

    In a pre-print published in The Lancet, which is yet to undergo peer-review, the researchers found that the Oxford vaccine had a similar effectiveness against the Kent variant than previous variants. It was also shown to decrease the viral load in people who have been vaccinated, meaning they are less likely to infect others.

    EU regulator approves Oxford vaccine

    The European Medicines Agency has approved the Oxford/AstraZeneca COVID-19 vaccine for use in adults. The vaccine is the third to be given approval from the regulator.

    Oxford man first to receive Oxford vaccine

    Health Secretary Matt Hancock hailed the approval of the Oxford vaccine as "pivotal moment" in the fight to stop the spread of COVID-19.

    The Oxford Vaccine – How generalisable are the trial results?

    "Oxford-AstraZeneca has devised a vaccine in an unprecedented amount of time... However, with any and all science, it is important that we be critical of the claims being made, and question the scientific method used to arrive at such conclusions."

    Oxford vaccine 7x cheaper than Pfizer’s

    The vaccine against COVID-19 being produced by the University of Oxford and AstraZeneca is likely to be cheaper and easier to roll out than...

    Oxford vaccine induces immune response in elderly people

    Analysis of the results from Phase II trials of the Oxford University COVID-19 vaccine has shown that it induces an immune response in older...